Rituximab for the treatment of rheumatoid arthritis: an update.

Drug Des Devel Ther · 2013 · PMC3883598 · PMID 24403823

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although this study was not powered to compare between rituximab doses, exploratory results showed a trend of more radiological protection with the higher dose, which is clinically relevant in RA patients with early disease.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.